CVS agreed to buy medical provider Coram from Apria Healthcare for roughly $2.1 billion, continuing its push into the specialty drug market.
via WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304747004579223793663456878.html?mod=pls_whats_news_us_business_f
via WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304747004579223793663456878.html?mod=pls_whats_news_us_business_f
Nessun commento:
Posta un commento